Abiomed
ABMD
#1254
Rank
HK$133.67 B
Marketcap
HK$2,965
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : HK$1.21 Billion

According to Abiomed's latest financial reports the company's total liabilities are HK$1.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31HK$1.33 B4.05%
2021-03-31HK$1.28 B9.39%
2020-03-31HK$1.17 B26.95%
2019-03-31HK$0.92 B21.29%
2018-03-31HK$0.76 B-0.54%
2017-03-31HK$0.76 B78.65%
2016-03-31HK$0.42 B17.89%
2015-03-31HK$0.36 B26.26%
2014-03-31HK$0.28 B12.47%
2013-03-31HK$0.25 B19.19%
2012-03-31HK$0.21 B2.68%
2011-03-31HK$0.20 B24.39%
2010-03-31HK$0.16 B8.43%
2009-03-31HK$0.15 B-18.59%
2008-03-31HK$0.19 B72.75%
2007-03-31HK$0.11 B56.12%
2006-03-31HK$70.5 M85.26%
2005-03-31HK$38.05 M1.31%
2004-03-31HK$37.56 M-22.9%
2003-03-31HK$48.72 M-38.75%
2002-03-31HK$79.54 M9.27%
2001-03-31HK$72.79 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Teleflex
TFX
HK$31.51 B 2,483.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
HK$148.43 B 12,069.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
HK$1.23 B 1.39%๐Ÿ‡บ๐Ÿ‡ธ USA